
John Matthew Mauro
Examiner (ID: 6494, Phone: (571)272-6070 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1622, 1625 |
| Total Applications | 896 |
| Issued Applications | 752 |
| Pending Applications | 0 |
| Abandoned Applications | 151 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14993493
[patent_doc_number] => 20190315704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => PROTECTION OF PLANT EXTRACTS AND COMPOUNDS FROM DEGRADATION
[patent_app_type] => utility
[patent_app_number] => 16/300537
[patent_app_country] => US
[patent_app_date] => 2017-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6264
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16300537
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/300537 | PROTECTION OF PLANT EXTRACTS AND COMPOUNDS FROM DEGRADATION | May 10, 2017 | Abandoned |
Array
(
[id] => 11851638
[patent_doc_number] => 20170226130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-10
[patent_title] => 'Ataxia Telengiectasia And Rad3-Related (ATR) Protein Kinase Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 15/498631
[patent_app_country] => US
[patent_app_date] => 2017-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 48835
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15498631
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/498631 | Ataxia telengiectasia and Rad3-related (ATR) protein kinase inhibitors | Apr 26, 2017 | Issued |
Array
(
[id] => 11834581
[patent_doc_number] => 20170216301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-03
[patent_title] => 'NOVEL BICYCLIC BROMODOMAIN INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/486256
[patent_app_country] => US
[patent_app_date] => 2017-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 90437
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15486256
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/486256 | Bicyclic bromodomain inhibitors | Apr 11, 2017 | Issued |
Array
(
[id] => 15227445
[patent_doc_number] => 10501432
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-10
[patent_title] => Chiral separation of D
[patent_app_type] => utility
[patent_app_number] => 15/473868
[patent_app_country] => US
[patent_app_date] => 2017-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6784
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 173
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15473868
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/473868 | Chiral separation of D | Mar 29, 2017 | Issued |
Array
(
[id] => 13153855
[patent_doc_number] => 10093638
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-09
[patent_title] => Utilizing a multiphase reactor for the conversion of biomass to produce substituted furans
[patent_app_type] => utility
[patent_app_number] => 15/468728
[patent_app_country] => US
[patent_app_date] => 2017-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 8201
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15468728
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/468728 | Utilizing a multiphase reactor for the conversion of biomass to produce substituted furans | Mar 23, 2017 | Issued |
Array
(
[id] => 13037313
[patent_doc_number] => 10040776
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-07
[patent_title] => Pyran derivatives and their preparation
[patent_app_type] => utility
[patent_app_number] => 15/448006
[patent_app_country] => US
[patent_app_date] => 2017-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6050
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15448006
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/448006 | Pyran derivatives and their preparation | Mar 1, 2017 | Issued |
Array
(
[id] => 16900720
[patent_doc_number] => 20210179636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => ANTIBACTERIAL COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/074853
[patent_app_country] => US
[patent_app_date] => 2017-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22963
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16074853
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/074853 | ANTIBACTERIAL COMPOUNDS | Feb 7, 2017 | Abandoned |
Array
(
[id] => 17975495
[patent_doc_number] => 11492343
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-08
[patent_title] => Polymorph of flibanserin and preparation method thereof and use of same
[patent_app_type] => utility
[patent_app_number] => 16/074130
[patent_app_country] => US
[patent_app_date] => 2017-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 3653
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16074130
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/074130 | Polymorph of flibanserin and preparation method thereof and use of same | Feb 2, 2017 | Issued |
Array
(
[id] => 11625777
[patent_doc_number] => 20170135967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-18
[patent_title] => 'FORMULATIONS COMPRISING 2-AMINO-2-[2-(4-OCTYLPHENYL)ETHYL]PROPANE-1,3-DIOL'
[patent_app_type] => utility
[patent_app_number] => 15/418831
[patent_app_country] => US
[patent_app_date] => 2017-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8035
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15418831
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/418831 | FORMULATIONS COMPRISING 2-AMINO-2-[2-(4-OCTYLPHENYL)ETHYL]PROPANE-1,3-DIOL | Jan 29, 2017 | Abandoned |
Array
(
[id] => 15948597
[patent_doc_number] => 10662187
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-26
[patent_title] => Bruton's tyrosine kinase inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/070520
[patent_app_country] => US
[patent_app_date] => 2017-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12571
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16070520
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/070520 | Bruton's tyrosine kinase inhibitors | Jan 16, 2017 | Issued |
Array
(
[id] => 12023572
[patent_doc_number] => 20170313671
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-02
[patent_title] => 'NEW SALT OF ABEXINOSTAT, ASSOCIATED CRYSTALLINE FORM, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM'
[patent_app_type] => utility
[patent_app_number] => 15/405021
[patent_app_country] => US
[patent_app_date] => 2017-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2643
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15405021
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/405021 | Salt or abexinostat, associated crystalline form, a process for their preparation and pharmaceutical compositions containing them | Jan 11, 2017 | Issued |
Array
(
[id] => 12305667
[patent_doc_number] => 09938254
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-10
[patent_title] => Antiproliferative compounds, and their pharmaceutical compositions and uses
[patent_app_type] => utility
[patent_app_number] => 15/400208
[patent_app_country] => US
[patent_app_date] => 2017-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34928
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 164
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15400208
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/400208 | Antiproliferative compounds, and their pharmaceutical compositions and uses | Jan 5, 2017 | Issued |
Array
(
[id] => 15147639
[patent_doc_number] => 20190352297
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-21
[patent_title] => SELECTIVE AURORA A KINASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/476295
[patent_app_country] => US
[patent_app_date] => 2017-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9382
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 175
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16476295
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/476295 | SELECTIVE AURORA A KINASE INHIBITORS | Jan 5, 2017 | Abandoned |
Array
(
[id] => 11589656
[patent_doc_number] => 20170114067
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-27
[patent_title] => 'METHOD OF TREATMENT USING SUBSTITUTED PYRAZOLO[1,5-A] PYRIMIDINE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 15/399389
[patent_app_country] => US
[patent_app_date] => 2017-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30473
[patent_no_of_claims] => 117
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15399389
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/399389 | Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds | Jan 4, 2017 | Issued |
Array
(
[id] => 12086764
[patent_doc_number] => 09840484
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-12-12
[patent_title] => 'Aryl compound and making method'
[patent_app_type] => utility
[patent_app_number] => 15/398838
[patent_app_country] => US
[patent_app_date] => 2017-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4067
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15398838
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/398838 | Aryl compound and making method | Jan 4, 2017 | Issued |
Array
(
[id] => 16268733
[patent_doc_number] => 20200270220
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => ASCOCHLORIN DERIVATIVE AND USE THEREOF AS AMPK ACTIVATOR
[patent_app_type] => utility
[patent_app_number] => 16/067930
[patent_app_country] => US
[patent_app_date] => 2017-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13541
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16067930
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/067930 | Ascochlorin derivative and use thereof as AMPK activator | Jan 3, 2017 | Issued |
Array
(
[id] => 16869946
[patent_doc_number] => 20210163413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => (E)-4-(4-ACRYLAMIDOPHENOXY)-N-METHYLPICOLINAMIDE CONJUGATES AS POTENTIAL ANTICANCER AGENTS
[patent_app_type] => utility
[patent_app_number] => 16/071105
[patent_app_country] => US
[patent_app_date] => 2017-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4316
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16071105
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/071105 | (E)-4-(4-acrylamidophenoxy)-N-methylpicolinamide conjugates as potential anticancer agents | Jan 3, 2017 | Issued |
Array
(
[id] => 13071549
[patent_doc_number] => 10056563
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-21
[patent_title] => Synthetic method of fused heteroaromatic compound and fused heteroaromatic compound, and intermediate thereof
[patent_app_type] => utility
[patent_app_number] => 15/392816
[patent_app_country] => US
[patent_app_date] => 2016-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9525
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 230
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15392816
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/392816 | Synthetic method of fused heteroaromatic compound and fused heteroaromatic compound, and intermediate thereof | Dec 27, 2016 | Issued |
Array
(
[id] => 14485045
[patent_doc_number] => 10329289
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-25
[patent_title] => 6,7-dihydro-5H-pyrrolo[3,4-B]pyridin-5-one allosteric modulators of the M4 muscarinic acetylcholine receptor
[patent_app_type] => utility
[patent_app_number] => 15/386009
[patent_app_country] => US
[patent_app_date] => 2016-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49355
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 470
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15386009
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/386009 | 6,7-dihydro-5H-pyrrolo[3,4-B]pyridin-5-one allosteric modulators of the M4 muscarinic acetylcholine receptor | Dec 20, 2016 | Issued |
Array
(
[id] => 11555116
[patent_doc_number] => 20170101362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-13
[patent_title] => 'ACID/SALT SEPARATION'
[patent_app_type] => utility
[patent_app_number] => 15/378830
[patent_app_country] => US
[patent_app_date] => 2016-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6741
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15378830
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/378830 | Acid/salt separation | Dec 13, 2016 | Issued |